top of page

2022 Rome Action Plan on Paediatric HIV & TB

Micro Labs

HIV MEDICINES DURING PREGNANCY AND BREASTFEEDING

Micro Labs commits to:

392. Finalize the development 3-medicine paediatric fixed-dose combination product (RHZ) for treatment of drug-sensitive TB, with an aim of submitting dossier to WHO PQ by Q3 of 2023.

Updates

 - 

bottom of page